In a recent "Fast Company" article, Oliver Wyman's Sam Glick explains his views on what the creation of a new and powerful trifold healthcare company means for the greater industry.
In the News
Terry Stone writes in The Hill on the critical need to partner with American businesses during this next phase of health reform.
Terry Stone on the need to push harder on initiatives that put focus on value, outcomes, and experience.
What is alert fatigue? And why is it having a devastating impact on patient care?
The article explores the economics of long-term care in nursing homes based on a project Oliver Wyman undertook on behalf of the Lien Foundation and the Khoo Chwee Neo Foundation.
Partner Sam Glick writes in Harvard Business Review on how healthcare companies are testing the limits of the power of repurposing online retail innovations.
The Deal features David Campbell on how healthcare companies can leverage royalties, not their balance sheets, to fund innovation.
How healthcare information can empower consumers, and the unique skill set IT innovators bring to the market.
Oliver Wyman's Health & Life Sciences global managing partner weighs in on consolidation, consumerism, and rising drug costs.
What does the new consumer healthcare market look like and what are the implications for cost and care?